Evidence map›Paper›PMID 39657007›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis.

Alice X T Xu, Kevin Brown, Kevin L Schwartz, Soheila Aghlmandi, Sarah Alderson, Jamie C Brehaut, Benjamin C Brown, Heiner C Bucher, Janet Clarkson, An De Sutter and 26 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Observational
  14. Review
  15. [Requirements for the rational use of antibiotics based on antibiotic stewardship].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  16. Article
  17. Article
  18. Practical and clinical significance of the pharmacist-led antimicrobial stewardship.Journal of pharmaceutical health care and sciences · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Alice X T XuPublic Health Ontario, Toronto, Ontario, Canada.ORCID 0000-0001-8405-0766
Kevin BrownPublic Health Ontario, Toronto, Ontario, Canada.
Kevin L SchwartzPublic Health Ontario, Toronto, Ontario, Canada.
Soheila AghlmandiPaediatric Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.ORCID 0000-0003-0180-3246
Sarah AldersonLeeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-5418-0495
Jamie C BrehautClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Benjamin C BrownCentre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID 0000-0001-9975-4782
Heiner C BucherPragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland.
Janet ClarksonSchool of Dentistry, University of Dundee, Dundee, United Kingdom.
An De SutterDepartment of Public Health and Primary Care, Center for Family Medicine UGent, Ghent University, Ghent, Belgium.
Nick A FrancisPrimary Care Research Centre, University of Southampton, Southampton, United Kingdom.
Jeremy GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-8015-8243
Ronny GunnarssonGeneral Practice / Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-9183-3072
Michael HallsworthThe Behavioural Insights Team, Brooklyn, New York, USA.
Lars HemkensPragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland.ORCID 0000-0002-3444-1432
Sigurd HøyeAntibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Tasneem KhanLeeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
Donna M LeckyPrimary Care & Interventions Unit, HCAI, Fungal, AMR, AMU& Sepsis Division, UK Health Security Agency, London, United Kingdom.ORCID 0000-0002-1223-9356
Felicia LeungLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Jeremy LeungFaculty of Science, McGill University, Montreal, Quebec, Canada.
Morten LindbækAntibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Jeffrey A LinderDivision of General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0003-2217-184X
Carl LlorUniversity Institute in Primary Care Research Jordi Gol, Via Roma Health Centre, Barcelona, Spain.ORCID 0000-0001-6644-717X
Paul LittlePrimary Care Research Centre, University of Southampton, Southampton, United Kingdom.
Denise O'ConnorSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Céline PulciniUniversité de Lorraine, APEMAC, Nancy, France.
Kalisha RamlackhanPublic Health Ontario, Toronto, Ontario, Canada.ORCID 0009-0008-5235-4253
Craig R RamsayHealth Services Research Unit, University of Aberdeen, Aberdeen, United Kingdom.
Pär-Daniel SundvallGeneral Practice / Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-9889-509X
Monica TaljaardClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Pia Touboul LundgrenDepartment of Public Health, Nice University Hospital, Nice, France.
Akke VellingaCARA Network, School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.ORCID 0000-0002-6583-4300
Jan Y VerbakelDepartment of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0002-7166-7211
Theo J VerheijJulius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The  Netherlands.
Carl WikbergGeneral Practice / Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Noah IversWomen's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0003-2500-2435

Funding

PREVENTABLE Vanguard PhaseU19AG065188 · NIA · DUKE UNIVERSITY · PI KAREN P ALEXANDER · 2019 to 2026
$96.2M
USC-Yale Roybal Center for Behavioral Interventions in AgingP30AG024968 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JASON N. DOCTOR, Daniella Meeker · 2004 to 2026
$14.7M
U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
The Claude D. Pepper Older Americans Independence Center (OAIC) at Northwestern UniversityP30AG059988 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ACKERMANN, RONALD T. · 2020 to 2024
$7.1M
Primary Care Detection of Cognitive Impairment Leveraging Health and Consumer Technologies in Underserved Communities: The MyCog TrialU01NS105562 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MICHAEL S WOLF, Julia Yoshino Benavente · 2022 to 2026
$6.8M
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care SettingsR01AG069762 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD, NOWINSKI, CINDY J. · 2020 to 2025
$6.4M
Development and Validation of a Telehealth Strategy for Routine Detection of Cognitive Impairment in Primary Care: The MyCog Mobile AssessmentR01AG074245 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI NOWINSKI, CINDY J., WOLF, MICHAEL S · 2021 to 2025
$3.8M
Study in Outpatient Medicine using Nudges to improve Sleep: The SOMNUS TrialR01HL167023 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JASON N. DOCTOR · 2023 to 2026
$2.6M
Reducing High Risk Polypharmacy Using Behavioral Economics through Electronic Health RecordsR01AG070054 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PERSELL, STEPHEN · 2022 to 2025
$1.9M
Reducing Racial and Ethnic Disparities in Medicare Annual Wellness Visit UptakeR21AG081895 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LISS, DAVID T · 2023 to 2023
$435k
AHRQ HHS R01 HS024930CIHR FRN 173704NHLBI NIH HHS R01 HL167023NIA NIH HHS P30 AG024968NIA NIH HHS P30 AG059988NIA NIH HHS R01 AG069762NIA NIH HHS R01 AG070054NIA NIH HHS R01 AG074245NIA NIH HHS R21 AG081895NIA NIH HHS R24 AG064025NIA NIH HHS U19 AG065188NINDS NIH HHS U01 NS105562
6 · The paper itself

Abstract

backgroundThis systematic review evaluates the effect of audit and feedback (A&F) interventions targeting antibiotic prescribing in primary care and examines factors that may explain the variation in effectiveness.

methodsRandomized controlled trials (RCTs) involving A&F interventions targeting antibiotic prescribing in primary care were included in the systematic review. Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, and ClinicalTrials.gov were searched up to May 2024. Trial, participant, and intervention characteristics were extracted independently by 2 researchers. Random effects meta-analyses of trials that compared interventions with and without A&F were conducted for 4 outcomes: (1) total antibiotic prescribing volume; (2) unnecessary antibiotic initiation; (3) excessive prescription duration, and (4) broad-spectrum antibiotic selection. A stratified analysis was also performed based on study characteristics and A&F intervention design features for total antibiotic volume.

resultsA total of 56 RCTs fit the eligibility criteria and were included in the meta-analysis. A&F was associated with an 11% relative reduction in antibiotic prescribing volume (N = 21 studies, rate ratio [RR] = 0.89; 95% confidence interval [CI]: .84, .95; I2 = 97); 23% relative reduction in unnecessary antibiotic initiation (N = 16 studies, RR = 0.77; 95% CI: .68, .87; I2 = 72); 13% relative reduction in prolonged duration of antibiotic course (N = 4 studies, RR = 0.87 95% CI: .81, .94; I2 = 86); and 17% relative reduction in broad-spectrum antibiotic selection (N = 17 studies, RR = 0.83 95% CI: .75, .93; I2 = 96).

conclusionsA&F interventions reduce antibiotic prescribing in primary care. However, heterogeneity was substantial, outcome definitions were not standardized across the trials, and intervention fidelity was not consistently assessed. Clinical Trials Registration. Prospero (CRD42022298297).

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug PrescriptionsPractice Patterns, Physicians'Primary Health CareFeedbackHumansInappropriate PrescribingRandomized Controlled Trials as TopicAnti-Bacterial Agentsantibioticsaudit and feedbackprimary caresystematic review

Identifiers

PMID39657007
PMCPMC11848270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.